Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acadia Pharmaceuticals | ACAD | Jan 17, 2025 | 17.57 | +0.29 |
Acadia Realty Trust | AKR | Jan 17, 2025 | 22.65 | -1.09 |
Acadian Asset Management | AAMI | Jan 17, 2025 | 24.97 | 0.00 |
Accel Entertainment | ACEL | Jan 17, 2025 | 10.72 | +0.85 |
Accelerate Diagnostics | AXDX | Jan 17, 2025 | 1.07 | -4.46 |
Accenture A | ACN | Jan 17, 2025 | 352.59 | +0.58 |
Acco Brands | ACCO | Jan 17, 2025 | 5.20 | -0.19 |
Accolade | ACCD | Jan 17, 2025 | 6.89 | +0.44 |
Accuray | ARAY | Jan 17, 2025 | 2.24 | -2.61 |
Acelyrin | SLRN | Jan 17, 2025 | 1.99 | 0.00 |
Achieve Life Sciences | ACHV | Jan 17, 2025 | 3.09 | +0.65 |
Achilles Therapeutics ADR | ACHL | Jan 17, 2025 | 1.14 | -0.87 |
ACI Worldwide | ACIW | Jan 17, 2025 | 53.84 | -0.92 |
Aclarion | ACON | Jan 17, 2025 | 0.04 | -6.00 |
Aclaris Therapeutics | ACRS | Jan 17, 2025 | 2.57 | +2.39 |
ACM Research A | ACMR | Jan 17, 2025 | 17.64 | -0.23 |
Acme United | ACU | Jan 17, 2025 | 37.20 | +1.69 |
ACNB | ACNB | Jan 17, 2025 | 39.58 | +2.30 |
ACRES Commercial Realty | ACR | Jan 17, 2025 | 17.68 | -0.11 |
ACRES Commercial Realty C Pref | ACR-C | Jan 17, 2025 | 24.77 | +0.24 |
ACRES Commercial Realty D Pref | ACR-D | Jan 17, 2025 | 22.19 | -0.36 |
Acrivon Therapeutics | ACRV | Jan 17, 2025 | 5.78 | +4.14 |
Actelis Networks | ASNS | Jan 17, 2025 | 1.51 | +8.63 |
Actinium Pharmaceuticals | ATNM | Jan 17, 2025 | 1.40 | +14.75 |
Active Bear ETF | HDGE | Jan 17, 2025 | 15.72 | -0.38 |
Active U.S. Real Estate Powershares | PSR | Jan 17, 2025 | 90.21 | +0.08 |
Actuate Therapeutics | ACTU | Jan 17, 2025 | 8.62 | +0.82 |
Acuity Brands | AYI | Jan 17, 2025 | 330.36 | -0.12 |
Acumen Pharmaceuticals | ABOS | Jan 17, 2025 | 1.65 | +2.48 |
Acurx Pharmaceuticals | ACXP | Jan 17, 2025 | 0.88 | +12.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.